WuXi Bo Rui Biotechnology

China
Genhe, Inner Mongolia, China
+86-10-60769188 ★

Company profile

WuXi Bo Rui Biotechnology company profile

WuXi Bo Rui Biotechnology develops a radioactive molecular imaging and nuclear drug transformation platform for the precise diagnosis and treatment of tumors. WuXi Bo Rui Biotechnology focuses on the transformation and development of new radionuclide drugs, covering multiple fields of small molecules, peptides, and antibodies, for the diagnosis and treatment of tumors, using their professional platform for targeted precursor design, screening, and radionuclide labeling. While increasing the efficiency of research and development, it also fully utilizes the benefits of accurate nuclear medicine diagnosis and treatment

Business identity

Contact email
[email protected]
Phone number
+86-10-60769188
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$10K+
Founded
2020-01-01

Headquarters

Headquarters
Genhe, Inner Mongolia, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$42M
Last funding
Series A / $42M / 2022-09-02
Last equity funding
Series A / $42M
Investors
5
Lead investors
1

Founders and investors

Lead investors

HSG

Investors

CTS CapitalHSGPuhua CapitalRiverHead CapitalTririver Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.